Download FREE Report Sample
Download Free sampleCarbapenem-Based Antibiotics Market contains market size and forecasts of Carbapenem-Based Antibiotics in Global, including the following market information:
Global Carbapenem-Based Antibiotics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Carbapenem-Based Antibiotics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Meropenem Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Carbapenem-Based Antibiotics include ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec and Pfizer Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Carbapenem-Based Antibiotics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Carbapenem-Based Antibiotics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Carbapenem-Based Antibiotics Market Segment Percentages, by Type, 2021 (%)
Meropenem
Doripenemu
Imipenem
Tebipenemu
Others
Global Carbapenem-Based Antibiotics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Carbapenem-Based Antibiotics Market Segment Percentages, by Application, 2021 (%)
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Global Carbapenem-Based Antibiotics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Carbapenem-Based Antibiotics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Carbapenem-Based Antibiotics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Carbapenem-Based Antibiotics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ACS Dobfar S.p.A
Iterum Therapeutics plc
DAEWOONG PHARMACEUTICAL CO.,LTD
Aurobindo Pharma Ltd
Gland Pharma Limited
Merck & Co., Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Savior Lifetec
Pfizer Inc.
Spero Therapeutics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
